Data / Form D filings / ENTRIGUE SURGICAL INC
ENTRIGUE SURGICAL INC: Form D filings
ENTRIGUE SURGICAL INC, a biotechnology company in San Antonio, TX, filed 3 Form D notices with the SEC between 2009 and 2011. The latest, on November 21, 2011, reports $4 million sold of a $4 million offering to 18 investors.
Find out what ENTRIGUE SURGICAL INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12672 SILICON DRIVE, SUITE 150, San Antonio, TX, 78249
- Phone
- (210) 298-6398
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2007
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1446076
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 21, 2011 | New notice | $4,000,000 | $4,000,000 | $0 | 18 | Oct 26, 2011 | sec.gov |
| May 5, 2010 | New notice | $11,378,232 | $10,878,234 | $499,998 | 14 | Apr 21, 2010 | sec.gov |
| Nov 25, 2009 | New notice | $3,300,000 | $3,171,773 | $128,227 | 8 | Sep 16, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joseph D. Oliver III | Executive Officer | |
| Anthony J. Natale | Director | |
| Richard B. Emmitt | Director | |
| John T. Treace | Director | |
| Gabriele G. Niederauer | Executive Officer | |
| Fred B. Dinger III | Executive Officer, Director | |
| Donald A. Gonzales | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Nov 21, 2011 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ENTRIGUE SURGICAL INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.